Welcure Drugs & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2025 ,inter alia, to consider and approve 1. To consider and approve the Unaudited Financial Results of the Company for the 1st quarter endedon 30th June, 2025.2. To change the Corporate Office of the Company.3. To appoint Mr. Ravi Thakor (DIN 11210729) as an Additional Non- Executive Non- IndependentDirector of the Company.4. To appoint Mr. Yogeshkumar Prajapati (DIN 11210767) as an Additional Non- ExecutiveIndependent Director of the Company.5. To appoint Mrs. Bhumika Pradhan (DIN 10167275) as an Additional Non- Executive IndependentDirector of the Company.6. To consider any other matter, with the permission of the Chair.